In 2019, 11 out of 26 biosimilars approved by the U.S. Food and Drug Administration reached the market, or 42%. Pfizer alone is expected to release three biosimilar products by early 2020 and with more approvals to come. With all the anticipated activity, the percentage of FDA-approved biosimilars should surpass 60% into the New Year. Whether your shipments are small or large molecule, high or low volume, Yourway has the expertise and capabilities to ensure your drug product reaches its destination safely and efficiently.